Introduction

Anticancer Agents from Natural Products

Volumn , Issue , 2005, Pages 1-4

  Cragg, Gordon M ^a   Kingston, David G I ^b   Newman, David J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHIPS; BIOSYNTHESIS; LEAD COMPOUNDS; METABOLITES;

ANTICANCER DRUG DISCOVERY; BIOSYNTHETIC PATHWAY; COMBINATORIAL CHEMISTRY; DRUG DISCOVERY RESEARCHES; MICROBIAL METABOLITES; NATIONAL CANCER INSTITUTE; NATURALLY OCCURRING; PHARMACEUTICAL RESEARCH;

DRUG PRODUCTS;

EID: 84875139197     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (8)

1. Williams, D.H. et al., Why are secondary metabolites (natural products) biosynthesized? J. Nat. Prod. 52, 1189, 1989.
2. Paul, V.J. Ecological Roles of Marine Natural Products . Cornell University Press, Ithaca, NY, 1992.
3. Kingston, D.G.I. and Newman, D.J. Mother Nature’s combinatorial libraries: Their influence on the synthesis of drugs. Curr. Opin. Drug Disc. Dev. 5, 304, 2002.
4. Shu, Y.-Z. Recent natural products based drug development: A pharmaceutical industry perspective. J. Nat. Prod. 61, 1053, 1998.
5. Newman, D.J., Cragg, G.M., and Snader, K.M. Natural products as sources of new drugs over the period 1981–2002. J. Nat. Prod. 66, 1022, 2003.
6. Newman, D.J., Cragg, G.M., and Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 17, 215, 2000.
7. Tulp, M. and Bohlin, L. (2002) Functional versus chemical diversity: Is biodiversity important for drug discovery? Trends Pharm. Sci. 23, 225, 2002.
8. Henkel, T., et al., Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew. Chem. Int. Ed., 38, 643, 1999.